Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 12, 2025Open Access

Multidrug-Resistant Bacteria (Superbugs): An Outlook on Emerging Global Health Threats

View Full Paper
Ask AI
Bookmark
Share

Authors

TDTiyasa DasRajiv Gandhi University of Health SciencesSMSohaumn MondalUniversity of SaskatchewanDSDeodhar SinghCentral Potato Research Institute

Discussion

Loading...

Member takes

Implication

This review reveals the rising challenge of antimicrobial resistance in global health, highlighting CRISPR and phage therapy as potential solutions.

Key Points

  • The emergence of multidrug-resistant superbugs poses a serious threat to global health and medicine.
  • By 2050, antimicrobial resistance is predicted to cause 8.22 million deaths due to excessive antibiotic use and horizontal gene transfer.
  • New strategies like β-lactamase inhibitors and phage therapy are vital to combat multidrug-resistant pathogens.
  • International collaboration and One Health-aligned policies are essential to manage and monitor antimicrobial resistance.

Cite This Study

Das et al. (2025) studied this question.

synapsesocial.com/papers/68ebc91af2c3e4d8d926e333https://doi.org/10.20944/preprints202510.0698.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Global Threat of Multidrug-Resistant Microorganisms: Implications for Human and Environmental Health2026
  2. 2Genomic Insights into Bacterial Antimicrobial Resistance Transmission and Mitigation Strategies2024 · 4 citations
  3. 3Environmental Antimicrobial Resistance: Key Drivers, Hotspots, Innovative Strategies, and Challenges in the Fight Against Superbugs2025 · 26 citations
  4. 4Antimicrobial resistance : Real threat for the clinician2024 · 4 citations
  5. 5Global governance is necessary to coexist with superbugs2024